RFK Jr. Faces Backlash Over Vaccine Policy Changes

Health care stakeholders are sounding alarms after a series of controversial actions by Health and Human Services Secretary Robert F. Kennedy Jr. that could undermine U.S. vaccine policy and coverage.

Kennedy has drawn widespread criticism for interfering with the Advisory Committee on Immunization Practices (ACIP), the independent CDC panel that makes vaccine recommendations. According to STAT News, Kennedy personally questioned ACIP members’ financial disclosures and pushed for the appointment of vaccine-skeptic experts, raising concerns about “radical transparency” being used to politicize scientific deliberations.

Simultaneously, multiple physician and pharmacy organizations are suing the Department of Health and Human Services, alleging that Kennedy’s policy to no longer enforce coverage requirements for all CDC-recommended vaccines violates the Affordable Care Act. The lawsuit, filed July 8, argues that HHS has acted unlawfully in stripping insurance plans of their obligation to cover recommended vaccines without cost-sharing.

This follows weeks of pressure from pharmacy groups, including the American Pharmacists Association and the National Alliance of State Pharmacy Associations, who have urged insurers and policymakers to preserve vaccine access amid fears of reduced uptake and widening disparities.

Kennedy defended the moves in a recent Boston Globe interview, stating that “Americans should not be coerced into taking vaccines” and promising to “rebuild trust” by giving more weight to dissenting scientific views. However, public health leaders warn that these changes could erode confidence in immunization programs and lead to declines in vaccination rates.

Key Takeaways for Hospital Leaders

  • Insurance Disruption: Hospitals should prepare for potential gaps in vaccine coverage, especially for pediatric and adult populations that rely on cost-free immunizations under the ACA. 
  • Patient Communication: Reassure patients about the safety and importance of recommended vaccines. Consider proactive outreach as misinformation may rise. 
  • Policy Advocacy: Health systems must engage with congressional delegations and HHS to preserve evidence-based ACIP processes and protect preventive care access. 
  • Monitor Legal Outcomes: The pending lawsuit against HHS could have significant implications for future preventive service mandates. Stay informed on its progress and any resulting policy changes. 

Hospital and health system leaders are urged to remain vigilant and vocal during this turbulent moment for public health policy.